C-nitroso compounds and use thereof
AssigneeDuke University
InventorsJonathan S. Stamler, Eric J. Toone
Life of this patent
Estimating the term…
Loading patent…
AssigneeDuke University
InventorsJonathan S. Stamler, Eric J. Toone
Estimating the term…
A C-nitroso compound having a molecular weight ranging from 225 to 1,000 (from 225 to 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less than about 25, is useful as an NO donor. When the compound is obtained from a carbon acid with a pKa less than about 10, it provides vascular relaxing effect when used at micromolar concentrations and this activity is potentiated by glutathione to be obtained at nanomolar concentrations. When the compound is obtained from a carbon acid with a pKa ranging from about 15 to 20, vascular relaxing effect is obtained at nanomolar concentrations without glutathione. In another embodiment, a biocompatible polymer incorporates a C-nitroso moiety.
A C-nitroso compound having a molecular weight ranging from about 225 to about 1,000 on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less than about 25.
A biocompatible polymer incorporating a C-nitroso moiety derived from a carbon acid with a pKa less than about 25, having a weight average molecular weight ranging from 50,000 to 500,000.
A C-nitroso compound containing the moiety.
A COX-2 inhibitor where a tertiary carbon atom and/or a sulfur atom and/or an oxygen atom is nitrosylated.
Dependencies are inferred from the claim text.